Peripheral administration of nanomicelle-encapsulated anti-Aβ oligomer fragment antibody reduces various toxic Aβ species in the brain

MLA

Akiko Amano, et al. “Peripheral Administration of Nanomicelle-Encapsulated Anti-Aβ Oligomer Fragment Antibody Reduces Various Toxic Aβ Species in the Brain.” Journal of Nanobiotechnology, vol. 21, no. 1, Jan. 2023, pp. 1–14. EBSCOhost, https://doi.org/10.1186/s12951-023-01772-y.

APA

Akiko Amano, Nobuo Sanjo, Wataru Araki, Yasutaka Anraku, Makoto Nakakido, Etsuro Matsubara, Takami Tomiyama, Tetsuya Nagata, Kouhei Tsumoto, Kazunori Kataoka, & Takanori Yokota. (2023). Peripheral administration of nanomicelle-encapsulated anti-Aβ oligomer fragment antibody reduces various toxic Aβ species in the brain. Journal of Nanobiotechnology, 21(1), 1–14. https://doi.org/10.1186/s12951-023-01772-y

Chicago

Akiko Amano, Nobuo Sanjo, Wataru Araki, Yasutaka Anraku, Makoto Nakakido, Etsuro Matsubara, Takami Tomiyama, et al. 2023. “Peripheral Administration of Nanomicelle-Encapsulated Anti-Aβ Oligomer Fragment Antibody Reduces Various Toxic Aβ Species in the Brain.” Journal of Nanobiotechnology 21 (1): 1–14. doi:10.1186/s12951-023-01772-y.